InsiderTrades

Form 4 for CNMD CONMED Corp

Accepted 2025-03-11 00:00:00 ET · period of report 2025-03-07 · accession 0001127602-25-009019 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-03-11 2025-03-07 CNMD Lalomia Brent VP QA, RA F - Tax $62.74 -26 1,006 -3% -$1,631
D 2025-03-11 2025-03-07 CNMD Lalomia Brent VP QA, RA M - OptEx $0.00 +75 1,032 +8% $0
D 2025-03-11 2025-03-07 CNMD Lalomia Brent VP QA, RA M - OptEx $0.00 -75 75 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-07 F D 26 $62.74 1,006.06 D — —
2 Common Common Stock 2025-03-07 M A 75 $0.00 1,032.06 D — —
3 Derivative RSUs (Restricted Stock Units) 2025-03-07 M D 75 $0.00 75 D $0.00 · — to 2032-03-07 75 Common Stock (F1) Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.